Delcath Systems (NASDAQ: DCTH)
$4.87
(-1.6%)
-$0.08
Price as of April 15, 2024, 4:00 p.m. ET
Delcath Systems Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Delcath Systems Company Info
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in New York, NY.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.